Bio-Techne Corp

Stage 2 · Advancing · week 13

As of Oct 22, 2026, Bio-Techne is in Stage 2, the uptrend phase, now in week 13 (since Jul 24, 2026). It closed at $72.62, at its 52-week high and above its 200-day average, which is rising.

$72.62

-0.03% today

$11.4B · Large cap

Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 110 in Biotechnology · #1 of 272 in Health Care

Is TECH early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 20w

S1 15w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 4w → S3 1w → S4 13w → S1 13w → S4 8w → S2 12w → S3 7w → S2 2w → S3 6w → S1 1w → S4 5w → S1 1w → S2 1w → S1 3w → S2 1w → S1 2w → S4 20w → S1 15w → S2 10w → S3 1w → S2 6w → S3 5w → S4 11w → S1 4w → S2 13w current

Total tracked: 165 weeks across 25 stage runs.

TECH among Biotechnology146th of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…146	TECHBio-Techne Corp	Stage 2 · wk 13	66	+0.1%

vs 52W High

-0.0%

$43.17 lo$72.64 hi

Near 52W high

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 13

1w13w26w

Week 13, proven structure

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

15.5%

200 DMA: $62.85 · rising

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

1.50x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

→

Short-term trend flat

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+0.1%

+1.5%

+39.5%

YTD

+22.3%

+15.1%

Scan Membership

Breakout Watch

Latest: 2025-02-06

11 appearances in last 60 days. First seen: 2018-10-16.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S2

Wk 13 · Vol 1.50x

2026-10-21S2

Wk 13 · Vol 1.26x

2026-10-20S2

Wk 13 · Vol 1.16x

2026-10-19S2

Wk 13 · Vol 0.91x

2026-10-16S2

Wk 12 · Vol 0.94x

2026-10-15S2

Wk 12 · Vol 0.86x

2026-10-14S2

Wk 12 · Vol 0.54x

2026-10-13S2

Wk 12 · Vol 0.85x

2026-10-12S2

Wk 12 · Vol 0.84x

2026-10-09S2

Wk 11 · Vol 0.75x

2026-10-08S2

Wk 11 · Vol 1.81x

2026-10-07S2

Wk 11 · Vol 1.03x

Moving averages & range

50 DMA

$72.40

200 DMA

$62.85

52W High

$72.64

52W Low

$43.17

5D Low

$72.49

Resistance levels (recent highs)

20d High

$72.64

60d High

$72.64

120d High

$72.64

250d High

$72.64

Next resistance

+0.0%

to 20d High

P/E (TTM)

62.6

Forward 31.4

ROE

+9.0%

Profit margin +15.0%

Dividend Yield

0.44%

P/B 5.4

Bio-Techne: quick answers

What stage is Bio-Techne in?

As of Oct 22, 2026, Bio-Techne (TECH) is in Stage 2, the uptrend phase. It entered Stage 2 on Jul 24, 2026 and is in week 13. What the four stages mean

Is Bio-Techne in an uptrend?

Yes. Bio-Techne is in a Stage 2 uptrend. It trades 15.5% above its 200-day average, which is rising.

How far is Bio-Techne from its 52-week high?

Bio-Techne closed at $72.62 on Oct 22, 2026, at its 52-week high. Its 52-week low is $43.17.

How has Bio-Techne performed over the past year?

As of Oct 22, 2026, Bio-Techne is up 15.1% over the past year and up 22.3% so far in 2026.

Which sector and industry is Bio-Techne in?

Bio-Techne is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. Its Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.